{
    "clinical_study": {
        "@rank": "166482", 
        "arm_group": [
            {
                "arm_group_label": "rehabilitation (MST) program", 
                "arm_group_type": "Experimental", 
                "description": "The Multidimensional Stimulation group therapy (MST) involved three levels of treatment. The first level was focused on PWA, the second level involved the caregiver, while the third one the dyad PWA-caregiver."
            }, 
            {
                "arm_group_label": "Usual care program", 
                "arm_group_type": "No Intervention", 
                "description": "Usual care PWA program"
            }
        ], 
        "brief_summary": {
            "textblock": "Our previous findings support the notion that group activity program, based on cognitive\n      stimulation, recreational-occupational activities and physical-psychomotor exercises, can\n      lead to an improvement in behavioral aspects for people with Alzheimer's Disease (AD).\n\n      The purpose of this study is to clarify the efficacy of a rehabilitation program in\n      outpatients affected by AD in mild to moderate stages."
        }, 
        "brief_title": "Multistimulation Group Therapy for Alzheimer's Disease", 
        "condition": "Alzheimer's Disease", 
        "condition_browse": {
            "mesh_term": "Alzheimer Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diagnosis of possible/probable AD\n\n          -  mild to moderate stage of AD (MMSE score of 15 - 24)and CDR score of 1-2\n\n          -  range years in age (65-85) and in school attendance (5-17)\n\n          -  right handed\n\n        Exclusion Criteria:\n\n          -  severe aphasia (Token test score < 20)\n\n          -  severe auditory and/or visual loss\n\n          -  overt severe behavioral disturbances (delusions, hallucinations, agitation)\n\n          -  recent (three month before the MST) introduction or dose modification of the\n             following pharmacological treatments: cholinesterase inhibitor, memantine,\n             antidepressant or antipsychotic drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01893398", 
            "org_study_id": "FdG_AD_01"
        }, 
        "intervention": {
            "arm_group_label": "rehabilitation (MST) program", 
            "description": "The MST program involved three levels of treatment. The first level was focused on PWA, the second level involved the caregiver, while the third one the dyad PWA-caregiver.", 
            "intervention_name": "Multidimensional stimulation group therapy", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 2, 2013", 
        "link": {
            "url": "http://www.dongnocchi.it/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Milan", 
                    "country": "Italy"
                }, 
                "name": "IRCCS, S Maria Nascente, FOndazione don Gnocchi"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multistimulation Group Therapy in Mild to Moderate Alzheimer's Disease", 
        "other_outcome": {
            "description": "Change from baseline in brain functioning. We used fMRI with cognitive task to detect possible changes (10 ws versus baseline) in brain activation patterns in PWA as a surrogate biomarker of efficacy.", 
            "measure": "Functional MRI", 
            "safety_issue": "No", 
            "time_frame": "baseline, 10 ws"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Neuropsychiatric Inventory scale", 
                "measure": "Change from baseline in behavioral level", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 10ws, 22ws"
            }, 
            {
                "description": "ADAS cog scale", 
                "measure": "Change from baseline in cognitive level", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 10ws, 22 ws"
            }, 
            {
                "description": "SF36 questionaire", 
                "measure": "Change from baseline in quality of life", 
                "safety_issue": "No", 
                "time_frame": "baseline, 10ws,22 ws"
            }
        ], 
        "reference": [
            {
                "PMID": "16777648", 
                "citation": "Farina E, Mantovani F, Fioravanti R, Pignatti R, Chiavari L, Imbornone E, Olivotto F, Alberoni M, Mariani C, Nemni R. Evaluating two group programmes of cognitive training in mild-to-moderate AD: is there any difference between a 'global' stimulation and a 'cognitive-specific' one? Aging Ment Health. 2006 May;10(3):211-8."
            }, 
            {
                "PMID": "11982487", 
                "citation": "Farina E, Fioravanti R, Chiavari L, Imbornone E, Alberoni M, Pomati S, Pinardi G, Pignatti R, Mariani C. Comparing two programs of cognitive training in Alzheimer's disease: a pilot study. Acta Neurol Scand. 2002 May;105(5):365-71."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01893398"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Fondazione Don Carlo Gnocchi Onlus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fondazione Don Carlo Gnocchi Onlus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}